Human Cellular Immune Response to the Saliva of Phlebotomus papatasi Is Mediated by IL-10-Producing CD8+ T Cells and Th1-Polarized CD4+ Lymphocytes by Abdeladhim, Maha et al.
Human Cellular Immune Response to the Saliva of
Phlebotomus papatasi Is Mediated by IL-10-Producing
CD8+ T Cells and Th1-Polarized CD4+ Lymphocytes
Maha Abdeladhim
1.,M e ´lika Ben Ahmed
1*
., Soumaya Marzouki
1, Nadia Belhadj Hmida
1, Thouraya
Boussoffara
2, Nabil Belhaj Hamida
3, Afif Ben Salah
3, Hechmi Louzir
1,2
1Department of Clinical Immunology, Pasteur Institute of Tunis, Tunis, Tunisia, 2LIVGM, Pasteur Institute of Tunis, Tunis, Tunisia, 3Department of Medical Epidemiology,
Pasteur Institute of Tunis, Tunis, Tunisia
Abstract
Background: The saliva of sand flies strongly enhances the infectivity of Leishmania in mice. Additionally, pre-exposure to
saliva can protect mice from disease progression probably through the induction of a cellular immune response.
Methodology/Principal Findings: We analysed the cellular immune response against the saliva of Phlebotomus papatasi in
humans and defined the phenotypic characteristics and cytokine production pattern of specific lymphocytes by flow
cytometry. Additionally, proliferation and IFN-c production of activated cells were analysed in magnetically separated CD4+
and CD8+ T cells. A proliferative response of peripheral blood mononuclear cells against the saliva of Phlebotomus papatasi
was demonstrated in nearly 30% of naturally exposed individuals. Salivary extracts did not induce any secretion of IFN-c but
triggered the production of IL-10 primarily by CD8+ lymphocytes. In magnetically separated lymphocytes, the saliva
induced the proliferation of both CD4+ and CD8+ T cells which was further enhanced after IL-10 blockage. Interestingly,
when activated CD4+ lymphocytes were separated from CD8+ cells, they produced high amounts of IFN-c.
Conclusion: Herein, we demonstrated that the overall effect of Phlebotomus papatasi saliva was dominated by the
activation of IL-10-producing CD8+ cells suggesting a possible detrimental effect of pre-exposure to saliva on human
leishmaniasis outcome. However, the activation of Th1 lymphocytes by the saliva provides the rationale to better define the
nature of the salivary antigens that could be used for vaccine development.
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Introduction
Leishmaniasis includes a heterogeneous group of diseases that
are caused by protozoan parasites of the genus Leishmania. The
disease ranges from asymptomatic infections to self-limiting
cutaneous lesion(s) or fatal visceral forms [1]. Leishmania parasites
are transmitted to the vertebrate hosts by the bite of sand flies.
During parasite inoculation in the host’s skin, the vector injects the
saliva that contains a large number of pharmacological compo-
nents [2–4]. Several observations indicate that sand fly saliva is
crucial in the establishment of leishmaniasis and disease
pathogenesis [5–7]. The mechanism by which the vector’s saliva
enhances leishmania infection remains to be clarified. Sand fly
saliva contains potent antihemostatic and vasodilatator com-
pounds as well as potentially immunomodulatory molecules that
can directly down-modulate macrophage effector functions and
facilitate the establishment of the infection [8,9]. The exacerbating
effects of saliva may also be related to the early release of
epidermal interleukin-4 (IL-4) [7]. Alternatively, it could be
ascribed to the development of an adaptive immune response
that would favor the commitment of a Th2 immunity against
Leishmania. In mice, pre-exposure to saliva completely abrogated
the effects of the sand fly saliva and protected the host from disease
progression [7,10,11]. This protective effect correlated with a
strong delayed-type hypersensitivity (DTH) response and an early
and increased in situ production of IFN-c and IL-12 [10]. Further
experiments demonstrated that immunization with PpSP15
(gi|15963509) from P. papatasi saliva resulted in protection which
was not ascribed to a humoral immune response [12]. Altogether,
these data strongly supported the possibility that leishmaniasis
could be prevented by vaccinating against sand fly saliva and
suggest that the protective effect of the saliva might be associated
with cell-mediated immunity. In humans, the data about the
cellular immune responses are scarce. Herein, we analyzed the
cellular immune response against the saliva of Phlebotomus papatasi
developed in individuals naturally exposed to sand fly bites and
demonstrated that the overall effect of Phlebotomus papatasi saliva
was dominated by the activation of peripheral IL-10-producing
www.plosntds.org 1 October 2011 | Volume 5 | Issue 10 | e1345CD8+ cells. Strikingly, the activation of IFN-c-producing CD4+ T
lymphocytes has been revealed after neutralization of IL-10
production or depletion of CD8 lymphocytes.
Methods
Ethic statement
All experiments were conducted according to the principles
expressed in the Declaration of Helsinki. The study was approved
by the ethic committee of Institute Pasteur of Tunis. All patients
provided written informed consent for the collection of samples
and subsequent analysis.
Study population and samples
Peripheral blood samples were drawn from 36 donors
(Table 1). The sampling has been performed on April, just
before the transmission season of cutaneous leishmaniasis in
Tunisia (between June and October). Ten donors (B1 to B10; age
range 27–52 years, mean 31.9 years) were living in Tunis, a non
endemic region for ZCL but in which the presence of P. papatasi
has been reported at low frequency [13]. Twenty-six (B11 to B36;
age range 15–73 years, mean 40.2 years) were living in Sidi
Bouzid, a region located in the center of Tunisia, which is endemic
for ZCL caused by Leishmania major and characterized by the
presence of P. papatasi at high frequencies [13].
Culture media and reagents
In all in vitro assays, cells were cultured in RPMI 1640 medium
supplemented with 10% AB human serum (Sigma, St Louis, MO),
1% sodium pyruvate, 1% non essential aminoacids, 1% HEPES
buffer, 5610
25 M/L b-mercaptoethanol and 40 mg/mL genta-
mycin, (Invitrogen, Cergy Pontoise, France).
Purified blocking anti-human IL-10 antibody (BD Biosciences,
Le Pont de Claix, France) was used in cell culture. The following
monoclonal antibodies were used for flow cytometry analysis:
FITC-, and Cy-Chrome-conjugated anti-human CD3, CD4 and
CD8, PE-conjugated anti-IL-4, IL-10, IFN-c, TNF-a, granzyme B
and control isotypes (BD Biosciences).
Salivary gland extract and soluble Leishmania antigen
preparation
Salivary glands from a Tunisian strain of Phlebotomus papatasi
were dissected out in phosphate buffer saline and disrupted by 3
freezing/thawing cycles. After centrifugation, the supernatants
were stored at –80uC. Just before use, the salivary gland extract
(SGE) was prepared by dilution in cell culture medium added with
gentamycin (Invitrogen).
Soluble Leishmania antigen (SLA) was prepared from an isolate of
L. major (zymodme MON25; MHOM/TN/94/GLC94), obtained
from ZCL lesion, as previously described [14].
Lymphocyte isolation and cell culture
Peripheral blood mononuclear cells (PBMC) were isolated on a
Ficoll-Hypaque gradient. In some experiments, lymphocyte
subsets were separated by negative selection using magnetic beads
(Miltenyi Biotec, Paris, France). Purity of T cell subsets ranged
from 95% to 98%.
Cells were cultured in 96-well plates in cell culture medium at
0.5610
6 cells/mL in a final volume of 200 mL and incubated with
SGE (1gland/mL) or SLA (10 mg/mL) with or without anti-IL-10
orisotype controlina 5%CO2 humidifiedatmosphereat37uC.The
optimum condition for PBMC proliferation against SGE was
determined in our laboratory in preliminary experiments. We thus
stimulated cells with different concentrations of salivary gland
extracts (0.25 gland/mL, 0.5 gland/mL, 1 gland/mL and 2 gland/
mL) for 3, 4 and 5 days and the optimal results (highest index of
proliferation corresponding to the ratio of cpm in stimulated
condition / unstimulated one) were obtained with 1 gland/mL
during five days. For proliferation studies, the uptake of (
3H)
thymidine (Amersham, Saclay, France) was measured 18 hours
after adding 0.4 mCi/well. Cells were harvested and the radioac-
tivity was counted in a scintillation counter (Rack Beta; LKB
Wallace). Results were expressed as a proliferation index: mean
counts of triplicates in antigen-stimulated cultures /mean counts of
triplicates in unstimulated cultures.
IL-10 and IFN-c detection assay
For IL-10 or IFN-c detection, supernatants of cell culture were
collected after 48h or 72h, respectively, centrifuged and stored at –
80uC until use. Capture enzyme-linked immunosorbent assay
(ELISA) was performed on supernatants using Human IL-10 or
IFN-c ELISA Sets (BD Biosciences) according to manufacturer’s
instructions. For each cytokine determination, the results were
interpolated from a standard curve using recombinant cytokines
and expressed in pg/mL or as ratio of IFN-c concentration in
stimulated/unstimulated cultures.
Flow cytometry analysis
Freshly isolated PBMC were stimulated for 24h to 96h with
SGE (1gland/mL) or medium alone in 24-well plates and treated
with Golgistop (BD Biosciences) for the last 6 hours of culture.
Cells were then washed and incubated with FITC or PE-Cy5.5
conjugated to CD3, CD4 or CD8 antibodies for 20 minutes at
4uC. For intracellular cytokine detection, the cells were fixed and
permeabilized using BD Cytoperm/cytofix plus kit (BD Biosci-
ences) according to manufacturer’s instructions and labeled with
PE-conjugated anti-human IFN-c, IL-4, IL-10, TNF-a, granzyme
B or control isotype (BD Biosciences). Analyses were performed
with a FACS Vantage flow cytometer using the CELLQuest
software (BD Biosciences).
Author Summary
Cutaneous leishmaniasis affects millions of people world-
wide and is caused by protozoa of the genus Leishmania.
The parasite is transmitted during sand fly bites. While
probing the skin for a blood meal, vectors salivate into the
host’s skin. Sand fly saliva contains several components
that increase hemorrhage and interfere with the host’s
inflammatory response. Data obtained in mice originally
indicate that immunization against saliva protected from
leishmaniasis supporting possibility that leishmaniasis
could be prevented by a vaccine based on sand fly saliva.
Herein we investigated the nature and the importance of
the cellular immune response developed against sand fly
saliva by individuals at risk of cutaneous leishmaniasis due
to Leishmania major. We demonstrated that the immunity
against saliva is dominated by the activation of lympho-
cytes producing a suppressive cytokine called IL-10. These
data may preclude the protective effect of sand fly saliva
pre-exposure in humans. Further experiments revealed
that the production of IL-10 masked the presence of a
second kind of lymphocytes producing IFN-c, a rather
protective cytokine. The latter finding highlights the
importance of the identification of the proteins activating
the latter lymphocytes in order to develop vaccines based
on selected proteins from the saliva of sand flies.
Cellular Immunity against Sand Fly Saliva
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Specific anti-saliva IgG antibodies were assessed by ELISA and
Western blot as previously described [15].
For ELISA, wells were coated with SGE (0.5 gland per well) in
0.1 M carbonate-bicarbonate buffer overnight at 4uC. The wells
were then washed in phosphate buffer (PBS) added with 0.1%
Tween 20 and incubated with PBS-Tween20–0.5% gelatin for 1
hour at 37uC to block free binding sites. Diluted sera (1:200) were
then incubated for 2 hours at 37uC. Antibody-antigen complexes
were detected using peroxidase-conjugated anti-human IgG
antibody diluted at 1:10000 (Sigma) for 1 hour at 37uC and were
visualized using Orthophenylendiamine in citrate buffer and
hydrogen peroxide. The absorbance was measured using an
automated ELISA reader (Awareness Technology Inc) at 492nm
wavelength. The cut-off for the assays was the mean optical
density obtained with sera of 20 negative controls obtained from
the study of Marzouki et al. [15] plus 3 standard deviations.
For Western-blot analysis, the equivalent of 40 to 60 salivary
glands were loaded in a single long well and separated on 15%
sodium dodecyl sulfate (SDS)-PAGE gel.The separated proteins were
Table 1. Clinical and biological features of the study population.











B1 F 28 - 1.22 1628 (0.98) Neg/Neg Not Applicable
B2 F2 3 - 5.49 4232 (5.79) Neg/Pos Not Applicable
B3 M 28 - 0.51 1119 (0.77) Neg/Neg Not Applicable
B4 M 27 - 1.20 797 (0.99) Neg/Neg Not Applicable
B5 F 29 - 1.34 499 (0.98) Neg/Neg Not Applicable
B6 M 26 - 0.86 3786 (2.46) Pos/Pos Not Applicable
B7 M5 2 - 12.20 1627 (0.79) Neg/Neg Not Applicable
B8 F 29 - 1.30 444 (0.99) Neg/Neg Not Applicable
B9 M 47 - 1.12 469 (0.64) Neg/Neg Not Applicable
B10 F 30 - 1.24 455 (0.99) Neg/Neg Not Applicable
B11 F2 5 + 5.68 7550 (3.84) Pos/Pos Not Applicable
B12 F2 2 - 27.34 5927 (8.83) Pos/Pos Not Applicable
B13 M5 2 - 33.36 516 (0.62) Pos/Pos Not Applicable
B14 M 18 - 0.80 378 (0.52) Neg/Neg Not Applicable
B15 M4 3 - 8.81 930 (0.95) Pos/Pos +
B16 M6 2 - 14.67 4975 (2.99) Pos/Pos +
B17 M7 0 + 42.75 494 (0.82) Neg/Pos -
B18 F2 7 + 17.76 681 (0.92) Pos/Pos +
B19 F3 4 + 29.46 409 (0.85) Neg/Pos +
B20 F1 9 - 11.37 3861 (2.19) Pos/Pos -
B21 F1 6 + 75.04 368 (0.82) Neg/Pos +
B22 F5 0 + 78.17 3440 (2.52) Neg/Pos +
B23 F1 5 + 45.60 372 (0.49) Pos/Pos +
B24 F4 8 + 54.39 360 (0.70) Pos/Pos +
B25 F 42 Not Applicable 9.786 884 (0.79) Neg/Pos +
B26 F4 2 - 32.89 395 (1.00) Pos/Pos +
B27 M5 0 + 13.30 961 (0.98) Pos/Pos +
B28 M3 3 + 16.75 407 (0.73) Pos/Pos -
B29 M4 3 + 22.71 4093 (2.1) Neg/Pos +
B30 M 48 Not Applicable 1.059 1653 (0.81) Pos/Pos -
B31 F 41 Not Applicable 7.78 7980 (4.75) Pos/Pos +
B32 F 49 Not Applicable 2.79 191 (0.5) Pos/Pos +
B33 F 43 Not Applicable 2.51 3656 (2.19) Pos/Pos +
B34 F 23 Not Applicable 4.80 290 (0.51) Neg/Pos +
B35 M 38 Not Applicable 7.74 5520 (4.23) Pos/Pos +
B36 M 54 Not Applicable 23.42 4107 (0.68) Pos/Pos +
M: Male; F: Female; SLA: Soluble Leishmania antigen; cpm: count per minute; index of stimulation = the ratio of cpm in stimulated condition / unstimulated one
Positive results regarding the cell proliferation against SLA and SGE (index above 2) and the antibody response against SGE are indicated in bold.
doi:10.1371/journal.pntd.0001345.t001
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incubated overnight at 4uC with blocking buffer containing 5% non-
fat milk and then cut into 8 to10 strips. Each strip was incubated for
one hour at room temperature with diluted serum samples (1:200).
After washing, the strips were incubated with horseradish peroxidase-
linked anti-human IgG antibody (Sigma) at 1:10000 for one hour at
room temperature. After five washings,positive bands were visualized
using enhanced chemiluminescence (Amersham).
Statistical analysis
Values obtained in two different groups were compared by the
non parametric Mann-Whitney U test using StatView software.
Statistics of results obtained as paired data were performed using
the Paired-T test. The correlation between different parameters
was analyzed using Spearman’s rank correlation. The exact Fisher
test was used to compare the frequency of individuals exhibiting a
positive proliferative response against the sand fly saliva between
the stratified groups of donors. Statistical significance was assigned
to a value of p,0.05.
Results
Salivary gland extracts from P. papatasi elicit PBMC
proliferation in exposed individuals
The cellular immune response against P. papatasi salivary gland
extracts (SGE) was first assessed by studying the proliferative
responses of peripheral blood mononuclear cells (PBMC) from our
donors. The optimum condition for the proliferation test has been
determined previously (namely, stimulation with 1 gland/ml of
SGE during five days of culture) (Figure S1). We designated as
positive SGE proliferation the cases exhibiting an index of PBMC
proliferation against the saliva of P. papatasi above 2. We thus
demonstrated that 11 out of 36 donors exhibited positive SGE
proliferation (Figure 1). The indices of proliferation obtained in
these donors were relatively low with a median of 3.2 but
significantly higher than those of donors with negative SGE
responses (p,0.0001) (Figure 1). The percentage of individuals
with positive SGE proliferation was higher in the group of donors
living in endemic area of leishmaniasis than in donors living in
northern parts of Tunisia (9 out of 26 donors versus 2 out of 10
donors). The difference was, however, not significant (p.0.05).
Twenty-six donors exhibited positive proliferation against SLA
(soluble Leishmania antigen). Except for B7 who has been
accidentally exposed to Leishmania parasites while manipulating
in a laboratory, the latter results suggest that these donors have
been exposed to infected sand fly bites. Consistently, in 18 out of
21 donors with positive proliferation against SLA, a delayed-type
hypersensitivity response against Leishmania antigens has been
demonstrated (Table 1). Interestingly, a cellular immune
response against SGE was more frequently noted in individuals
who exhibited a PBMC proliferation against SLA compared to
those with no proliferation against SLA (10 out of 26 donors versus
1 out of 10 donors) (Table 1). However, no correlation was found
between the level of proliferative responses against SGE and this of
proliferation against SLA (soluble Leishmania antigen) in all studied
donors (p.0.05) (Table 1 and Figure 1). In donors with a
cellular immune response against L. major (positive proliferation
against SLA), no association between proliferative responses
against SGE and the presence or absence of a past history of
ZCL was found (p.0.05) (data not shown).
Cellular immune response against salivary gland extract
is dominated by IL-10 and IL-4 secretion
Cellular immune responses against SGE were further tested by
monitoring cytokine secretion in supernatants of stimulated PBMC.
IFN-c was detected at a median concentration of 96 pg/ml in
unstimulated PBMC (data not shown). In supernatants of SGE-
stimulated cells, concentrations of IFN-c were not significantly
Figure 1. Salivary gland extracts of Phlebotomus papatasi induce proliferation of PBMC in previously exposed individuals. Peripheral
blood mononuclear cells (PBMC) were isolated from 36 volunteer donors; 10 donors (B1 to B10) were from a non endemic region for ZCL and 26
individuals (B11 to B36) were from endemic areas. PBMC (0.5610
6 cells/mL) were stimulated in 96-well plates with salivary gland extracts at one
gland/ml during five days. Proliferative responses were assessed by (
3H) thymidine uptake. Results were expressed as an index of proliferation (mean
counts of triplicates in antigen-stimulated cultures /mean counts of triplicates in unstimulated cultures) in all tested individuals. We designated as
positive SGE proliferation the cases exhibiting an index of PBMC proliferation above 2. The indices of proliferation obtained in such donors were
relatively low with a median of 3.2 but significantly higher than those obtained in donors with negative SGE responses (p,0.0001).
doi:10.1371/journal.pntd.0001345.g001
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and median levels were comparable in individuals with positive and
negative proliferation against SGE (median concentrations 93 pg/
ml versus 90 pg/ml respectively, p=0.63) (Figure 2A). While
IL-10 was detected at a median concentration of 28pg/ml in
unstimulated PBMC (data not shown), IL-10 concentration in
supernatants of stimulated PBMC was significantly increased in
individuals showing a specific proliferation against SGE (me-
dian concentration of 128 pg/ml, p,0.0001) but not individuals
with negative proliferation (median concentration of 23 pg/ml)
(Figure 2B). When the threshold of IL-10 induction was defined as
the 95
th percentile of the values obtained in individuals with
negative proliferation,wefoundthat IL-10wassignificantlyinduced
in stimulated PBMC from all but one of the individuals showing
proliferative response against SGE (Figure 2B). Conversely, in one
donor (B13) with negative proliferation against SGE, IL-10 level in
supernatants of SGE-stimulated PBMC was quite superior to the
threshold (Figure 2B). Interestingly, a significant correlation was
observed between proliferation and IL-10 induction in stimulated
PBMC from all donors (p=0.0002) (Figure 2C). Finally, the
effects of SGE on IL-10 production did not seem to be related to
LPS contamination as no difference in IL-10 production by PBMC
stimulated with SGE with or without polymyxin B was observed.
Moreover, TNF-a was not induced after SGE stimulation.
To better define the features of the cellular population activated
by the salivary gland extract, we focused our study on five
representative donors (identified as B2, B6, B11, B12 and B20)
from the group of donors showing proliferative response against
SGE. These donors were selected as they covered the different
range of proliferation positivity and were demographic matched to
the remaining of the cohort (2 from the non endemic area and 3
from the endemic area). Intracytoplasmic expression of cytokines
(IFN-c, IL-10, IL-4 and TNF-a) and granzyme B was studied by
flow cytometry in freshly isolated peripheral cells obtained from
these donors.
In accordance with data obtained above, SGE did not induce
IFN-c production at any of the tested time points (Figure 3A).
Similar results were obtained after stimulation by phorbol
myristate acetate (PMA) and ionomycin, used to increase the
sensitivity of the test (data not shown). Contrastingly, SLA
(Soluble Leishmania antigen) induced in donors B2, B11, B12 and
B20 (with positive proliferation against such antigen), the
production of high amounts of IFN-c (data not shown).
Similarly, TNF-a secretion was not induced by SGE
(Figure 3B). By contrast, IL-10 was detected in 4.8% to 11%
of total PBMC that have been stimulated with SGE (Figure 4A
and not shown). Surprisingly, IL-10 was produced primarily by
CD8+ T lymphocytes and CD3-negative cells. Indeed, SGE
Figure 2. Salivary gland extracts of Phlebotomus papatasi induce IL-10 secretion by human PBMC in immune individuals. Purified
peripheral blood mononuclear cells (0.5610
6 cells/mL) were stimulated with salivary gland extract of P. papatasi. IFN-c (A) and IL-10 (B) secretion was
evaluated in supernatants of cultures by an ELISA test at day 3 and day 2, respectively. Results were expressed as cytokine concentrations in
stimulated cultures for individuals with or without PBMC proliferation against salivary gland extract. The threshold was calculated as the 95
th
percentile of the values obtained in individuals with negative proliferation. Horizontal bars indicate median levels of cytokines. The correlation
between IL-10 concentrations in supernatants of stimulated cells and proliferative responses in all tested donors was represented in (C).
doi:10.1371/journal.pntd.0001345.g002
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CD8+ T cells (Figure 4A and 4B). Notably, we also performed
flow cytometry analyses in two individuals (B3 and B8) living in
non endemic area of leishmaniasis and who did not exhibit neither
PBMC proliferation nor IL-10 production after stimulation with
SGE. No cytokine production was detected (Figure 4A and not
shown).
The detection of specific CD8+ T cells was rather unexpected.
The induction of granzyme B was assessed after SGE stimulation
to determine whether these cells displayed cytotoxic functions. As
shown in Figure 4C, granzyme B was detected in almost 11% of
unstimulated CD8+ T lymphocytes. The percentage of granzyme-
B-producing-CD8+ cells did not increase after SGE stimulation
(median percentage of 7.62% in stimulated versus 7.15% in
unstimulated cells, p.0.05). This suggests that SGE did not
activate cytotoxic CD8+ T lymphocytes. By contrast, the
percentage of IL-4-producing CD8+ T lymphocytes increased
after SGE stimulation from a mean percentage of 2.03% to 4.87%
further supporting that activated CD8+ T cells are Th2 cells
(Figure 4D and not shown). Contrasting with results obtained
with IL-10, SGE stimulation did not induce a substantial IL-4
production by CD3 negative cells (Figure 4D).
Salivary gland extract from Phlebotomus papatasi elicits a
cellular immune response mediated by CD8+ T cells of
Th2 phenotype and IFN-c- producing CD4+ T cells
We then tested whether the high production of IL-10 by CD8+
lymphocytes and CD3-negative cells could account for the
relatively low proliferation of PBMC and the absence of IFN-c
production in response to SGE. Blocking anti-IL-10 antibody was
used at different concentrations since the amount of IL-10
detected in the supernatants of stimulated lymphocytes was
variable from one donor to another. As shown in Figure 5A and
5B, adding a blocking IL-10 antibody significantly enhanced the
proliferation and IFN-c production of stimulated PBMC from
individuals with positive proliferation (B2, B6, B11, B12 and B20).
To better define the subsets of T cells that were activated by the
saliva of Phlebotomus papatasi, the same experiments were subse-
quently performed on CD4+ and CD8+ T lymphocytes
magnetically separated from PBMC of donors that exhibited
proliferative responses to SGE. As shown in Figure 6A, SGE
induces the proliferation of both CD4+ and CD8+ T lymphocytes.
Blocking the production of IL-10 significantly enhanced the
proliferation of CD8+ T lymphocytes. This suggests that the
activated CD8+ T cells produce high amounts of IL-10 inhibiting
Figure 3. Salivary gland extracts of Phlebotomus papatasi did not induce IFN-c or TNF-a production in stimulated PBMC. Freshly
purified peripheral blood mononuclear cells (0.5610
6 cells/mL) from 5 individuals (B2, B6, B11, B12 and B20) were stimulated with salivary gland
extracts of P. papatasi at 1 gland/ml during 96h. Intracytoplamic expression of IFN-c (A) and TNF-a (B) was studied from days 2 through 4 by flow
cytometry in CD3 membrane stained-cells. The result from individual B11 is shown.
doi:10.1371/journal.pntd.0001345.g003
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considerable proliferation of CD4+ T cells that was only slightly
enhanced after IL-10 blockage (Figure 6A). SGE did not induce
any IFN-c production by CD8+ T lymphocytes confirming that
the specific CD8+ T lymphocytes were not Th1 cells (Figure 6B).
However, when the PBMC was depleted from CD8+ T cells and
stimulated with SGE, they produced a high amount of IFN-c and
this was further increased when IL-10 was neutralized
(Figure 6B). Intracytoplasmic analyses performed in donors
B2, B6, B11, B12 and B20 confirmed that the neutralization of IL-
10 as well as the depletion of CD8+ cells induces the production of
IFN-c by stimulated CD4+ T lymphocytes (Figure 6C and not
shown). The percentage of IFN-c-producing cells within the
stimulated-CD4 T cells varied from 0.93% to 1.54% when IL-10
was blocked and from 0.89% to 1.81% after CD8-depletion.
Furthermore, the mean of fluorescence of IFN-c staining of the
activated-CD4 T cells increased after IL-10 blockage or CD8-
depletion (Figure 6C and not shown). For instance, in CD4 T
cells from CD8-depleted PBMC, the mean fluorescence of IFN-c
staining increased from 21.4 to 34.7 after IL-10 blockage.
Altogether, these results demonstrate that SGE induces the
activation of CD8+ T cells of Th2 phenotype as well as Th1-
polarized CD4+ T lymphocytes that are probably suppressed by
IL-10- producing CD8+ T cells.
Discussion
Previous studies in mice suggested that salivary components
can be used to design vaccines able to control Leishmania infection
and stressed the role of cellular immunity as correlate for
protection [10–12;16,17]. In humans, few data have been
obtained on cellular immunity against sand fly saliva in
volunteers experimentally exposed to the bites of uninfected P.
papatasi [18] or Lutzomyia longipalpis [19]. In the present study, we
analyzed the cellular immunity developed by naturally exposed
individuals against P. papatasi sand fly saliva and demonstrated
that salivary gland extract from uninfected sand flies induces the
activation of IL-10 and IL-4-producing CD8+ T cells as well as
IFN-c-secreting CD4+ T lymphocytes.
Figure 4. Salivary gland extracts of Phlebotomus papatasi activate IL-10- and IL-4-producing CD8 T lymphocytes. Freshly purified
peripheral blood mononuclear cells (PBMC at 0.5610
6 cells/mL) from 4 (B2, B6, B11 and B12) or 5 individuals (B2, B6, B11, B12 and B20) were
stimulated with salivary gland extract of P. papatasi at 1 gland/ml. Intracytoplamic expression of IL-10 (A and B), Granzyme B (C) and IL-4 (D) was
studied by flow cytometry at day 3 in CD3, CD4 and CD8 membrane stained-cells. Cytokine staining was analyzed in the lymphocyte gate, on
CD4+CD3+ gated cells (T CD4) or on CD8+CD3+ gated cells (T CD8). In panel A, C and D, the results from one representative donor (B11) who exhibits
proliferative response to SGE are shown. Additionally, the result from the donor A3 with no proliferative response to SGE, is shown in panel A.
doi:10.1371/journal.pntd.0001345.g004
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immunized against the saliva of P. papatasi, our strategy consisted
of studying individuals who have high risk of contact with the
vector of L. major. The studied population comprised individuals
living in an endemic area of L. major transmission in Tunisia and
thus at risk of being exposed to sand fly bites. We also included
individuals who live in non endemic areas of cutaneaous
leishmaniasis as the presence of Phlebotomus papatasi has also been
reported in these areas [13]. We first assessed the proliferation and
cytokine secretion of PBMC after stimulation with salivary gland
extracts. A specific proliferative response of PMBC was evident in
nearly 30% of donors. A similar percentage (24%) has been
recently confirmed in a large number (n=425) of individuals
naturally exposed to sand fly bites (Kammoun et al. in
preparation). Interestingly, the proliferative response was more
frequently observed in individuals with a cellular immunity against
Leishmania, a result that might reflect a more frequent exposure to
sand fly bites in endemic areas. The positive cellular response
against SGE was also reported in two out of the ten volunteers
living in Tunis, corroborating the data reporting the presence of P.
papatasi in the northern parts of Tunisia [13]. Except for the donor
B7 who has been accidentally exposed to Leishmania antigens while
manipulating parasites in the laboratory, 15 individuals exhibit
positive proliferation against SLA but did not develop any cellular
response to SGE. Such donors, however, developed specific
antibodies against saliva as demonstrated by ELISA and/or
Western blot analysis (Table 1), thus indicating a previous
contact with the saliva of P. papatasi. For such donors, it seems that
there was no correlation between the antibody and the cellular
response. To our knowledge, the proliferative immune response
toward the saliva of sand flies was not previously described in the
literature although several works reported the presence of specific
antibodies in people naturally exposed to sand fly bites. One
possible explanation is the dominance of IL-10 production in
response to the saliva of P. papatasi. This IL-10 will inhibit both
proliferation and IFN-c production of CD4 T cells. Furthermore,
humans are outbred and therefore very diverse in term of pattern
of immune response.
In contrast with results showing an increased production of
IFN-c at the inoculation site in mice sensitized with P. papatasi
salivary proteins [10], our data did not detect any IFN-c
production by stimulated PBMC at all tested time-points.
Noticeably, monitoring cytokine production by PBMC either on
supernatant cell culture or using intra-cytoplasmic analysis
revealed an increased synthesis of IL-10. The induction of IL-10
by sand fly saliva was previously reported in mice [20]. The
production of IL-10, particularly by innate effectors such as
macrophages, may explain the enhancing effect of the saliva on
leishmania infectivity. Accordingly, in vitro experiments have
demonstrated that the saliva from either P. papatasi or L. longipalpis
exhibit immunosuppresive effects on macrophages and reduce the
nitric oxid production [8,9,21]. The latter effect was ascribed to
adenosine [22], an immunomodulatory component of P. papatasi
saliva known to induce IL-10 [23]. In humans, however, little is
known about the cytokine pattern activated by sand fly saliva.
While the saliva of L. longipalpis can activate both IFN-c and IL-10
Figure 5. Effect of anti-IL-10 blocking antibody on lymphocytes stimulated with salivary gland extracts of Phlebotomus papatasi.
Total PBMC (0.5610
6 cells/mL) from donors B2, B6, B11, B12 and B20 were stimulated with salivary gland extract (1 gland/ml) for 5 days in the
presence of blocking anti-IL-10 or isotype control at the indicated concentrations. (A) Proliferative responses were assessed by (
3H) thymidine uptake.
Results were expressed as index of proliferation: mean counts of triplicates in antigen-stimulated cultures /mean counts of triplicates in unstimulated
cultures. (B) IFN-c secretion was evaluated in supernatants of cultures at day 3 using an ELISA test. Results were expressed as a ratio of cytokine levels
in stimulated/unstimulated cultures.
doi:10.1371/journal.pntd.0001345.g005
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P. papatasi inhibit the production of IFN-c from L. major-stimulated
PBMC[24], aneffectwhichmaybe ascribedto IL-10.Interestingly,
in our study, blocking IL-10 enhanced the proliferation of
stimulated PBMC suggesting that IL-10 production may explain
the relatively low rate of PBMC proliferation and perhaps the
difficulty of detecting a proliferative response against SGE either in
humans or in mice (unpublished data). Accordingly, Rohousova et
al. reported an inhibitory effect of P. papatasi saliva on lymphocyte
proliferation in mice [25]. Yet, despite the fact that IL-10 suppresses
the proliferation of PBMC, we demonstrated that the production of
IL-10 was mainly detected in the cells, which proliferated in
response to SGE. Such paradoxical data could be easily explained.
In fact, the induction of IL-10 by SGE could be illustrated only in
patients who were previously exposed to Phlebotomus papatasi bites
and so exhibiting proliferative responses to SGE. Interestingly, in
one donor who exhibited a moderate production of IL-10 by
stimulated PBMC, the cell proliferation was demonstrated only
when the effect of IL-10 was blocked. In a current prospective work
studying the cellular immune response of four hundred donors
living in endemic areas of leishmaniasis in Tunisia, similar results
were obtained and in approximately 10% of donors, the proli-
ferative response of SGE-stimulated PBMC was revealed after IL-
10 neutralization (Kammoun et al. manuscript in preparation).
Interestingly, the five donors included in our study to define the
phenotype of activated cells by SGE have been chosen as they
covered the different range of proliferation against saliva and were
demographic matched to the remaining donors of the cohort.
Among them, four were in contact with Leishmania while one
was not. The cellular immune response against the saliva was
comparably dominated by IL-10 production whatever the donor
has been in contact with the parasite or not. Indeed, the level of IL-
10 in the supernatant of SGE stimulated PBMC was similar in the 5
donors(datanotshown). AlthoughSLAandSGEdo notactivate
the same effector cells, some experiments in which PBMC were co-
stimulated with both antigens were performed. Adding SLA did not
Figure 6. Effect of IL-10 blockage and CD8 cell depletion on lymphocytes stimulated with salivary gland extracts of Phlebotomus
papatasi. Total peripheral blood mononuclear cells (PBMC) or PBMC depleted of CD4+ or CD8+ T lymphocytes from donors B2, B6, B11, B12 and B20
(0.5610
6 cells/mL) were stimulated with salivary gland extract (1 gland/ml) for 5 days in the presence or not of anti-IL-10 blocking antibody at 500ng/
ml. (A) Proliferative responses were assessed by [
3H] thymidine uptake. Results were expressed as index of proliferation: mean counts of triplicates in
antigen-stimulated cultures /mean counts of triplicates in unstimulated cultures. (B) IFN-c secretion was evaluated in supernatants of cultures at day
3 using an ELISA test. Results were expressed as a ratio of cytokine levels in stimulated/unstimulated cultures. * p,0.05 when compared to the
condition with SGE. Data are representative of 5 distinct experiments. (C) Intracytoplamic expression of IFN-c was studied by flow cytometry at day 3
in total (upper panels) or CD8-depleted PBMC (lower panels). Cytokine staining was analyzed in the lymphocyte gate, on CD4+CD3+ gated cells.
Result from one representative individual (B11) is shown.
doi:10.1371/journal.pntd.0001345.g006
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dominated by IL-10 (data not shown).
Unexpectedly, our analysis of the activated cells revealed that
CD8+ T lymphocytes were a major source of IL-10 synthesis.
Detection of T CD8+ specific T cells was rather unexpected and
the analysis of IL-4 expression confirmed the Th2 phenotype of
these cells. This is the first account in which SGE-specific CD8+ T
cells of Th2 phenotype were reported in humans. In mice, Mbow
et al. reported a direct enhancing effect of P. papatasi saliva on IL-4
expression in the absence of Leishmania infection [26]. Another
study revealed large numbers of IL-10 producing CD4+ and
CD8+ T cells in draining lymph node of mice injected with SGE.
However, since SGE was co-injected with the parasite, the direct
effect of the saliva remains uncertain [20]. In donors with positive
proliferation against SGE, a significant percentage of CD3
negative cells (detected on the lymphocyte gate) also produced
IL-10 when stimulated with SGE. Preliminary experiments using
CD14 and CD16 staining suggest that these cells were not
monocytes or NK cells. B lymphocytes could be a possible cellular
source of IL-10. Analysis of such hypothesis is under progress as it
could bring new insights consistent with the recent literature
showing the role of regulatory B lymphocytes in autoimmunity
and infectious diseases [27,28].
Compellingdatasuggest that the protective effect of pre-exposure
to saliva in mice results from the skewing of the anti-leishmania
immunity towards a Th1 protective response [10,12]. Strikingly,
our experiments showed that in donors exhibiting proliferative
response against SGE, the presence of IFN-c-producing CD4+ T
lymphocytes could be revealed after neutralization of IL-10
production or depletion of CD8 lymphocytes. This indicates that
the overall effect of P. papatasi saliva, which is dominated by the
production of IL-10, may inhibit the activation of the specific Th1
cells. One may thus expect that the recall of IL-10-producing T
lymphocytes in individuals previously sensitized with sand fly saliva
would lead to the commitment of the immunity to Leishmania
towards a Th2 response. This would be consistent with the lack of a
protective effect of the pre-exposure to sand fly saliva in humans.
Accordingly, epidemiological data indicate that the incidence of
cutaneous leishmaniasis in the Old World is high in endemic areas
despite the common occurrence of bites from uninfected sand flies
[29]. Furthermore, recent studies indicate that the presence of
antibodies against the saliva of P. papatasi in individuals living in
endemic areas of ZCL in Tunisia was associated with an increased
risk of disease [H. Louzir, personal communication, 15]. In the
current prospective work mentioned above, monitoring either the
cellular and humoral immune response against sand fly saliva in
people living in endemic areas of cutaneous leishmaniasis
throughout several transmission seasons could provide some clues
regarding the effect of such immunity on the natural history of
leishmaniasis. Strikingly, the effect of pre-exposure to saliva on the
outcome of leishmaniasis in humans may differ from the reported
effect in mice. Even in mice, conflicting results were obtained when
the saliva of other species of sand flies was used [30]. Interestingly, a
recent report from Rohousova et al. [31] gave an attractive
explanation to the conflicting data between the possible non-
protective role of sand fly bites suggested by observations from the
field and the experimental data on mice. Indeed, the authors
showed that the protective effect of pre-exposition to Phlebotomus
duboscqi bites was limited to short-term exposure while a long-term
exposure regimen to saliva, a scheme close to what occur in
naturally exposed individuals to sand fly bites, was not protective.
The authors hypothesized that an immunization with a large
antigen load tends to skew the immune system towards a Th2
response, which could not be associated with protection.
Saliva is composed of a large broad of proteins. Variations in the
protein composition and antigenicity of the saliva from different
sand fly species may account for the conflicting results obtained
from different studies [32]. Genetic differences between hosts may
also underlie the disparity of the immune responses elicited by
salivary proteins from the same sand fly species [17,33] and may
perhaps explain the putative differential effects of the P. papatasi
saliva between humans and mice. Additionally, the sand fly saliva
may elicit a response that differs from that elicited by its separate
proteins [16]. For instance, distinct pattern of immune response
could be induced by different salivary proteins from P. papatasi
resulting in contrasting outcomes of L. major infection in mice [16].
PpSP15 had a protective effect, which correlated with a Th1
anti-Leishmania immune response whereas PpSP44 (gi|15963519)
exacerbated the disease. Our data indicate that the saliva of P.
papatasi can stimulate human CD4+ and CD8+ T cells with
contrasting cytokine profiles thereby suggesting the implication of
different salivary components in the activation of these populations.
Defining these salivary proteins would be crucial to predict their
specific effects on the outcome of leishmaniasis and to determine
potential vaccine candidates.
Salivary antigens that are introduced in the host skin are drained
to the lymph node where the immune response is triggered after
activation of circulating lymphocytes. Reactivation of an acquired
immunity against the saliva may lead to protection or exacerba-
tion of L. major infection by skewing the immunity against the
concomitantly inoculated Leishmania antigens to a Th1 or Th2
pattern, respectively. Several data obtained in mice suggested that
the immunity against sand fly saliva might also act on Leishmania
infection by creating an inhospitable in situ environment for the
establishment of parasites. Hence, it would be critical to cha-
racterize the nature and phenotype of cells that are recruited in situ
following exposure to bites of uninfected sand flies.
To our knowledge, this is the first account that describes the
different features of the adaptive cellular immunity against the
sand fly saliva in humans. When tested in the whole PBMC,
salivary gland extracts from P. papatasi induced a low rate of
proliferation, which contrasted with significant levels of IL-10 and
the absence of IFN-c. Preliminary results suggest that the CD8+ T
cells activated by the saliva of P. papatasi could be cd T
lymphocytes and that the target components might be adenylated
antigens as recently described [34,35]. These data need however
further confirmation. Whatever the target salivary component
triggering the activation of IL-10 producing cells, this pattern of
immune response may favor the Leishmania infection and facilitate
the multiplication of the parasite co-injected with the saliva. Our
data also demonstrated the activation of specific IFN-c-producing
CD4+ T cells that was revealed after the separation of T cell
subsets. This is of great interest as it provides a new rationale for
immunological approaches targeting the salivary components
activating a Th1 response that could be useful for vaccination
against leishmaniasis.
Supporting Information
Figure S1 Preliminary experiments determining the
optimal condition for cell proliferation with salivary
gland extracts of Phlebotomus papatasi. Peripheral blood
mononuclear cells (PBMC) were isolated from 3 volunteer donors
living in endemic area for ZCL (B11, B12 and B13). PBMC
(0.5610
6 cells/mL) were stimulated in triplicates in 96-well plates
with salivary gland extracts at different concentrations (0.25
gland/mL, 0.5 gland/mL, 1 gland/mL and 2 gland/mL) for 3, 4
and 5 days. Proliferative responses were assessed by (
3H) thymidine
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B12. Results are expressed as mean of cpm (count per minute)
obtained in triplicates. The optimal results (highest index of
proliferation corresponding to the ratio of cpm in stimulated
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